Inventor · disambiguated record
Sierra Jones Collier
Also filed as: COLLIER SIERRA JONES
13 granted patents·5 pending applications·275 citations·filing 2013–2023
95Inventor score
Top patents by PatentIndex Score
18 records- 0198US8734802B1Methods of treating vasomotor symptoms using antibodiesLABRYS BIOLOG INC·Filed 2013·Granted May 27, 2014·54 cites·20 claims
- 0298US8597649B2Antagonist antibodies directed against calcitonin gene-related peptide and methods using sameLABRYS BIOLOG INC·Filed 2013·Granted Dec 3, 2013·51 cites·9 claims
- 0397US9884907B2Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptideTEVA PHARMACEUTICALS INT GMBH·Filed 2017·Granted Feb 6, 2018·15 cites·18 claims
- 0497US9884908B2Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptideTEVA PHARMACEUTICALS INT GMBH·Filed 2017·Granted Feb 6, 2018·15 cites·18 claims
- 0597US9346881B2Antagonist antibodies directed against calcitonin gene-related peptide and methods using sameLABRYS BIOLOG INC·Filed 2015·Granted May 24, 2016·16 cites·19 claims
- 0697US9340614B2Antagonist antibodies directed against calcitonin gene-related peptide and methods using sameLABRYS BIOLOG INC·Filed 2015·Granted May 17, 2016·16 cites·20 claims
- 0797US9266951B2Antagonist antibodies directed against calcitonin gene-related peptide and methods using sameLABRYS BIOLOG INC·Filed 2015·Granted Feb 23, 2016·23 cites·19 claims
- 0897US9115194B2Antagonist antibodies directed against calcitonin gene-related peptide and methods using sameLABRYS BIOLOG INC·Filed 2014·Granted Aug 25, 2015·26 cites·20 claims
- 0996US9890210B2Antagonist antibodies directed against calcitonin gene-related peptideTEVA PHARMACEUTICALS INT GMBH·Filed 2017·Granted Feb 13, 2018·11 cites·15 claims
- 1096US9890211B2Antagonist antibodies directed against calcitonin gene-related peptideTEVA PHARMACEUTICALS INT GMBH·Filed 2017·Granted Feb 13, 2018·11 cites·15 claims
- 1196US9365648B1Methods of using anti-CGRP antagonist antibodiesLABRYS BIOLOG INC·Filed 2016·Granted Jun 14, 2016·16 cites·29 claims
- 1296US9328168B2Methods of using anti-CGRP antagonist antibodiesLABRYS BIOLOG INC·Filed 2015·Granted May 3, 2016·16 cites·30 claims
- 1393US10329343B2Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptideTEVA PHARMACEUTICALS INT GMBH·Filed 2018·Granted Jun 25, 2019·5 cites·24 claims
- 1490US2024158481A1Antagonist Antibodies Directed Against Calcitonin Gene-Related Peptide and Methods Using SameTEVA PHARMACEUTICALS INT GMBH·Filed 2023·Application pending·0 cites
- 1579US2022056114A1Antagonist Antibodies Directed Against Calcitonin Gene-Related Peptide and Methods Using SameTEVA PHARMACEUTICALS INT GMBH·Filed 2021·Application pending·0 cites
- 1678US2020247878A1Antagonist Antibodies Directed Against Calcitonin Gene-Related Peptide and Methods Using SameTEVA PHARMACEUTICALS INT GMBH·Filed 2019·Application pending·0 cites
- 1772US2019092841A1Antagonist Antibodies Directed Against Calcitonin Gene-Related Peptide and Methods Using SameTEVA PHARMACEUTICALS INT GMBH·Filed 2018·Application pending·0 cites
- 1866US2017081395A1Antagonist antibodies directed against calcitonin gene-related peptide and methods using sameTEVA PHARMACEUTICALS INT GMBH·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sierra Jones Collier files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →